NGM Biopharmaceuticals Inc. Stock Forecast
NGM Biopharmaceuticals Inc. stock price down 0% on Wednesday
(Updated on May 01, 2024)
No changes to the price of NGM Biopharmaceuticals Inc. stock on the last trading day (Wednesday, 1st May 2024). During the last trading day the stock fluctuated 0% from a day low at $1.54 to a day high of $1.54. The price has been going up and down for this period, and there has been a 0% change for the last 2 weeks.
The stock is moving within a very wide and horizontal trend and further movements within this trend can be expected. Given the current horizontal trend, you can expect NGM Biopharmaceuticals Inc. stock with a 90% probability to be traded between $1.41 and $1.94 at the end of this 3-month period. A break of a horizontal trend is often followed by a large increase in the volume, and stocks seldom manage to go directly from the bottom of a trend up to the top. Stocks turning up in the middle of a horizontal trend are therefore considered to be potential runners.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
NGM Signals & Forecast
There are mixed signals in the stock today. The NGM Biopharmaceuticals Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $1.54 and $1.55. A break-up above any of these levels will issue buy signals. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued. A buy signal was issued from a pivot bottom point on Thursday, April 04, 2024, and so far it has fallen 0%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD).
Support, Risk & Stop-loss for NGM Biopharmaceuticals Inc. stock
NGM Biopharmaceuticals Inc. finds support from accumulated volume at $1.53 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
In general the stock tends to have very controlled movements and therefore the general risk is considered very low. However, be aware of low or falling volume and make sure to keep an eye on the stock During the last day, the stock moved $0 between high and low, or 0%. For the last week the stock has had daily average volatility of 0%
Our recommended stop-loss: $1.45 (-6.00%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 19 days ago.)
Trading Expectations (NGM) For The Upcoming Trading Day Of Thursday 2nd
For the upcoming trading day on Thursday, 2nd we expect NGM Biopharmaceuticals Inc. to open at $1.54, and during the day (based on 14 day Average True Range), to move between $1.53 and $1.55, which gives a possible trading interval of +/-$0.0134 (+/-0.87%) up or down from last closing price. If NGM Biopharmaceuticals Inc. takes out the full calculated possible swing range there will be an estimated 1.74% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $1.55 (0.65%) than the support at $1.53 (0.65%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Earnings coming up
NGM Biopharmaceuticals Inc. will release earnings BMO on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.300. We will update the financials statements for NGM Biopharmaceuticals Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 5.27% in the first trading day after earnings release.
Is NGM Biopharmaceuticals Inc. stock A Buy?
NGM Biopharmaceuticals Inc. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score: 0.000 Hold/Accumulate Unchanged
Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.
Predicted Opening Price for NGM Biopharmaceuticals Inc. of Thursday, May 2, 2024
Fair opening price May 2, 2024 | Current price |
---|---|
$1.54 ( 0%) | $1.54 |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for NGM
Fibonacci Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.54 | . | |
R2 | 1.54 | . | ||
R1 | 1.54 | . | ||
Current price: | 1.54 | |||
Support | S1 | 1.54 | . | |
S2 | 1.54 | . | ||
S3 | 1.54 | . |
Accumulated Volume Support & Resistance Levels
Level | Price | |||
---|---|---|---|---|
Resistance | R3 | 1.63 | 5.84 % | |
R2 | 1.56 | 1.30 % | ||
R1 | 1.55 | 0.649 % | ||
Current price | 1.54 | |||
Support | S1 | 1.53 | -0.649% | |
S2 | 1.53 | -0.97% | ||
S3 | 1.52 | -1.30% |
FAQ
Click here for our free guide on how to buy NGM Biopharmaceuticals Inc. Stock.